Myocardial involvement in anti-phospholipid syndrome: Beyond acute myocardial infarction

Volume: 21, Issue: 3, Pages: 102990 - 102990
Published: Mar 1, 2022
Abstract
Anti-phospholipid antibodies (aPL) are the serological biomarkers of anti-phospholipid syndrome (APS), an autoimmune disorder characterized by vascular events and/or pregnancy morbidity. APS is a unique condition as thrombosis might occur in arterial, venous or capillary circulations. The heart provides a frequent target for circulating aPL, leading to a wide variety of clinical manifestations. The most common cardiac presentation in APS,...
Paper Details
Title
Myocardial involvement in anti-phospholipid syndrome: Beyond acute myocardial infarction
Published Date
Mar 1, 2022
Volume
21
Issue
3
Pages
102990 - 102990
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.